Trial Profile
Study to Evaluate Safety and Therapeutic Efficacy of a Combination Therapy of Oncoxin, a Nutritional Supplement and Surafenib, a Multikinase Inhibitor in Patients With Hepatocellular Carcinoma
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Arginine/ascorbic-acid/cinnamic-acid/cysteine/epigallocatechin-gallate/magnesium-sulfate/pyridoxine/repagermanium/zinc-sulfate (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 14 Jan 2013 New trial record